Amarillo Biosciences Warrant 2022-29.07.27 on Ainos AIMDW 深 沪
等待开盘 11-02 09:30:00 美东时间
0.0305
0.000
0.00%
华盛通- 最 高0.00
- 今 开0.0305
- 成交量 186股
- 最 低 0.00
- 昨 收 0.0305
- 总市值 0
- 52周最高 0.19
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.0251
- 委 比 -38.13%
- 总股本 --
- 历史最高 0.949
- 量 比 0.26
- 振 幅 0.00%
- 历史最低 0.025
- 每 手 1
- 风险率 0.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ainos Announces AI Nose Platform Hits Over 3B Chemical Data Points
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that its AI Nose platform has accumulated more than 3 billion real-world chemical data points, surpassing three times the 1 billion milestone announced in September. The rapid expansion of its real-world dataset stren...
10-30 21:02
Ainos Completes Required Data Delivery And Technology Transfer Under Its VELDONA License Deal For $600K Initial License Payment
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has completed the required data delivery and technology transfer under its VELDONA® license agreement, triggering a $600,000 initial license payment. The licensing partner confirmed completion in writing on Se...
09-30 21:10
Ainos Receives Three New Japanese Patents For Its AI Nose Technologies
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has secured three new Japanese patents covering AI Nose technologies and their integration with robotic systems.
09-09 20:02
Ainos Notes Review Of Its One-Year, AI-Analyzed Breath Pattern Study Focusing On Chronic Obstructive Pulmonary Disease
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into machine-readable data for artificial intelligence applications, today highlighted a new update report published by VASRO GmbH ("VASRO") reviewing Ainos' planned expansion of its AI Nose platf...
06-22 21:11
Ainos Activates Phased Industrial Deployment Roadmap To Install Up To 20K AI Nose Units
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced the activation of a phased industrial deployment roadmap under a strategic framework that contemplates the installation of up to 20,000
02-23 21:42
Ainos Collaborates With Mirle Automation To Integrate Ainos' AI Platform Into Robots, Quadruped Robots
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced a technology partnership with Mirle
02-02 21:14
Ainos Secures Seven New Patents In Europe, Germany, Taiwan, And China, Enhancing Its AI Nose Digital Olfaction Platform For Robotics Applications
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced it has secured seven new patents in Europe, Germany, Taiwan and China that strengthen its AI
2025-09-30 20:32
Ainos, Inc Announces Its Investigational Low-Dose Oral Interferon-Alpha Drug Candidate, Veldona Has Received Formal Approval From Taiwan's Food And Drug Administration To Initiate A Clinical Study For Primary Sjögren's Syndrome
Advancing a Novel, Side-Effect-Free Treatment for a Rare Yet Widely Underserved Autoimmune DiseaseAinos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Texas incorporated, dual-platform AI and biotech
2025-08-04 20:04
Ainos Regains Nasdaq Compliance, Accelerates AI Nose Platform Commercialization With 90-Day Execution Plan
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization, today announced it has regained compliance with the minimum bid price requirement for continued listing on
2025-07-16 20:09
